Delivery Order SPE2DB22D3501-SPE2DB25FUA47

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,374.59 firm fixed-price contract is for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription medication. The contract has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a prescription medication. The contract has a ceiling value of $2,680.50 and a period of performance through January 7, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, with a ceiling value of $4,391.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription medication. The contract has an ultimate completion date of July 5, 2024 and was awarded on July 3, 2024. It is a firm fixed-price contract type with no set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,203.18, is for the supply of RYTARY ER 48.75 MG-195 MG capsules. The contract has a firm fixed price pricing type and a period of performance through January 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product, with a ceiling value of $1,256.40 and an ultimate completion date of June 17, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $16,807.45 firm fixed price contract is for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S medication. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $4,603.83, is for the supply of RYTARY ER 23.75 MG-95 MG CAP 100S, a prescription pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of September 27, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,817.65, is for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S medication. The contract has a ceiling value of $1,244.90 and runs through October 29, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order award to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,325.53 firm fixed-price contract is for the supply of RYTARY ER 23.75 MG-95 MG CAP 100S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUA47
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,587.45, is for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S medication. This is a firm fixed-price contract with an ultimate completion date of January 6, 2025.

The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/4/25, 9:59 AM